logo
Devil's in the details: Why BP's debt may deter a buyer

Devil's in the details: Why BP's debt may deter a buyer

Time of India6 hours ago

BP
has been the subject of
takeover talks
for several years due to its shares' relative underperformance, but analysis of its disclosures shows the British energy firm may not be as cheap as its market valuation would indicate.
BP says it has net
debt
of $27 billion - already more than some rivals - but its disclosures show that it has around $38 billion of additional liabilities.
"We see BP's all-in debt profile as something of a poisoned chalice for an acquirer,"
RBC
analysts said.
The $80 billion company has underperformed its competitors for years, which investors and analysts say has made the company a potential takeover target.
Companies seen as potential suitors have included British rival
Shell
, along with U.S. oil majors such as Exxon Mobil or Chevron.
Live Events
Abu Dhabi National Oil Company considered a takeover in 2024, but did not proceed, Reuters reported.
BP declined to comment.
SHARES UNDERPERFORM
BP's stock has underperformed its peers since 2020 when its pivot to renewable energy left it lagging behind when global and gas prices surged.
Despite new CEO Murray Auchincloss reversing course, the shares have continued to underperform in 2025.
COMPLEX LIABILITIES
Beyond its declared net debt of $27 billion, BP carries three major additional liabilities.
The largest of these are some $17 billion in hybrid bonds which blend debt and equity traits. While they pay fixed income like bonds, issuers can skip payments, making them riskier and costlier. These often do not count as debt, helping preserve credit ratings. TotalEnergies holds about $12 billion in hybrids, while Shell has none.
BP also has $12.5 billion in lease obligations for assets such as vessels and rigs. Unlike Shell, which includes $28.5 billion of such liabilities in its $41.5 billion net debt, BP excludes them.
Finally, BP is still paying for the 2010 Macondo disaster, when a blowout at an offshore platform in the Gulf of Mexico caused one of the world's worst oil spills.
BP still owes $8 billion from the spill, part of a $70 billion total cost, company disclosures show. This remaining liability is also excluded from its net debt.
RATIOS
Shell CEO Wael Sawan has long argued that buying back Shell's own stock offers better value than investing in BP.
Analysts point to BP's higher all-in debt load as a key reason.
While BP's share price may appear cheap, financial measures such as EV/DACF (enterprise value/debt-adjusted cash flow), which compares a firm's value to its cash generation, tell a different story.
"BP's stock may look inexpensive from a share price point of view, but that masks the additional liabilities needing to be absorbed, with the current shares trading largely in line with Shell on EV/DACF," said UBS analyst Joshua Stone.
BP's valuation could improve if it completes its $20 billion
asset disposal plan
by 2026. But for now, it remains more leveraged than Shell, which limits its free cash flow.
"Overall, we still believe it likely that no deal will be agreed. BP carries significantly more debt than Shell," said Henry Tarr, co-head of energy and environment research at Berenberg. "This leverage eats into its free cash flow generation."
($1 = 0.7357 pounds)

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Shell in early talks to acquire London-based oil rival BP: Reports
Shell in early talks to acquire London-based oil rival BP: Reports

Business Standard

time18 minutes ago

  • Business Standard

Shell in early talks to acquire London-based oil rival BP: Reports

BP is under intense pressure after years of under-performance and the intervention of aggressive activist shareholder Elliott Investment Management Bloomberg Royal Dutch Shell Plc is in early talks to acquire BP Plc, which is considering the approach carefully, the Wall Street Journal reported. Shares of BP traded in New York jumped as much as 10% to $32.94. BP is under intense pressure after years of under-performance and the intervention of aggressive activist shareholder Elliott Investment Management. Speculation has been growing that the London-based company would become a takeover target, and Bloomberg reported in May that Shell had been studying the merits of a deal. A successful combination of Shell and BP would become one of the oil industry's largest-ever takeovers, bringing together the iconic British majors in a transaction that's been discussed on and off for decades. The companies were once close rivals — with a similar size, reach and global clout — but their paths have diverged in recent years after BP moved too quickly into low-carbon energy.

Trump shares NATO chief's private text praising 'decisive action' on Iran
Trump shares NATO chief's private text praising 'decisive action' on Iran

India Today

time35 minutes ago

  • India Today

Trump shares NATO chief's private text praising 'decisive action' on Iran

The message started by congratulating Donald Trump on his 'decisive action in Iran' and then got even more flattering, gushing about reaching the precipice of achieving 'something NO American president in decades could have done.'This wasn't an ardent supporter swooning or the president taking to social media to sing his own praises in his familiar ALL CAPS style. This was NATO Secretary-General Mark Rutte heaping direct praise on Trump as he flew to a two-day NATO summit in the President, dear Donald,' Rutte's message began, as seen by a screenshot Trump posted on his social media network. 'Congratulations and thank you for your decisive action in Iran, that was truly extraordinary, and something no one else dared to do. It makes us all safer.' The fawning tone may have been an attempt to butter up Trump ahead of a key meeting — the kind of effusive praise that British Prime Minister Keir Starmer has adopted lately in negotiating and then announcing a recent trade agreement between the United Kingdom and the U.S. that is meant to ease Trump's promised steep tariffs on imported British continued, 'You are flying into another big success in The Hague this evening. It was not easy but we've got them all signed onto 5 percent!' — a reference to other NATO member countries mostly having signed onto the new pledge to spend 5% of their gross domestic product on defence, a demand the Republican president has pushed for months.'Donald, you have driven us to a really, really important moment for America and Europe, and the world. You will achieve something NO American president in decades could get done,' Rutte wrote. 'Europe is going to pay in a BIG way, as they should, and it will be your win. Safe travels and see you at His Majesty's dinner!'NATO confirmed that the message came from Rutte and was sent on Tuesday. It declined to provide more details, like what platform the secretary-general used to send the message appeared, from the style of font and screen icons present in Trump's posting, that it could be the encrypted messaging app Signal, where communications can be set to auto-delete, raising questions about the potential difficulties of retaining them as official records as part of presidential was at the centre of the scandal in which Defence Secretary Pete Hegseth was accused of using the app, which is unapproved and unsecured, to share classified material about an upcoming U.S. airstrike in March on the Houthi rebel group in vigorously defended Hegseth, even declaring, 'I have no idea what Signal is. I don't care what Signal is.' He also said, though, 'I would frankly tell these people not to use Signal.'The White House said Tuesday that the message is authentic and was transmitted to Trump through staff on a government device — but would not speak to whether it was sent via Signal or another messaging isn't the first time a leader has sent a message that he then blasted out for all to see on social media.- EndsTune InMust Watch

Bharat Biotech, GSK to slash malaria vax prices to less than $5 per dose by 2028
Bharat Biotech, GSK to slash malaria vax prices to less than $5 per dose by 2028

Time of India

timean hour ago

  • Time of India

Bharat Biotech, GSK to slash malaria vax prices to less than $5 per dose by 2028

HYDERABAD: Vaccine maker Bharat Biotech International Ltd and British biopharma giant GSK plc will be slashing the prices of the world's first malaria vaccine – RTS,S or Mosquirix – by over half to less than $5 per dose by 2028 as part of their pledges to Gavi's replenishment process for 2026-2030. Tired of too many ads? go ad free now The proposed price reduction will be driven by process improvements, expanded production capacity, cost- effective manufacturing, and minimal profit margins, they said in a joint statement on Wednesday. The vaccine, developed by GSK, global non-profit PATH and partners, was the first malaria vaccine to be recommended by the World Health Organization (WHO) in 2021. The same year Bharat Biotech entered into a product transfer agreement with them to manufacture the vaccine in India. As part of the pact, GSK will be transferring the technology for the antigen part of the vaccine to Bharat Biotech and has also granted a licence on all rights for the vaccine, with Bharat Biotech taking over the complete manufacturing of the vaccine by 2028 and enabling the price reduction to below $5 per dose. GSK said it has made significant investments to enhance production capacity and efficiency, and to undertake the planned technology transfer to Bharat Biotech. Bharat Biotech, on the other hand, has invested over $200 million in setting up new, higher- output manufacturing facilities, product development and technology transfers. 'These enhancements have enabled a phased reduction in the price of the malaria vaccine, starting immediately and fully realised by 2028, when the transfer of production between the two companies is complete,' the joint statement said. Bharat Biotech executive chairman Dr Krishna Ella said the pledge is more than a pricing announcement and is a commitment to global equity, innovation, and collaboration. Tired of too many ads? go ad free now 'By joining forces with GSK, and working closely with Gavi, and the WHO, we are taking a real step toward closing the gap between vaccine supply and the urgent needs of children at risk of malaria.' GSK's chief global health officer Thomas Breuer said his company had partnered with Bharat Biotech in 2021 with a common goal to find a sustainable solution to malaria. 'The GSK team has worked hand in hand with Bharat Biotech to transfer the vaccine manufacturing technology, while simultaneously implementing crucial improvements in manufacturing efficiencies, resulting in today's pledge to the Gavi replenishment,' he said.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store